Byvalson, a medication used to treat symptoms of carcinoid syndrome, is available through a patient assistance program for eligible individuals. The program offers free medication to uninsured patients who meet certain income requirements [1]. For insured patients, co-pay assistance may be available, which can cover a portion of the out-of-pocket costs [1].
How much does Byvalson cost without insurance?
The price of Byvalson without insurance can vary significantly depending on the pharmacy and the quantity prescribed. While specific retail prices are not publicly disclosed, the cost without insurance is typically substantial, highlighting the importance of patient assistance programs [1].
What is the Byvalson patient assistance program?
The Byvalson patient assistance program is designed to help individuals who cannot afford their medication. To qualify, patients usually need to be U.S. residents, have a valid prescription, and demonstrate financial need. Details on eligibility criteria and how to apply are available from the drug manufacturer or through healthcare providers [1].
Can I get Byvalson through a co-pay card?
Yes, insured patients may be able to reduce their out-of-pocket expenses for Byvalson through a co-pay assistance program. This program typically helps cover a portion of the co-payment required by insurance plans [1].
Where can I find information about Byvalson financial assistance?
Information regarding financial assistance for Byvalson can be obtained from the prescribing physician's office or by contacting the pharmaceutical company that manufactures the drug directly [1]. They can provide details on eligibility, application procedures, and other available support resources.
What is carcinoid syndrome?
Carcinoid syndrome is a condition that can occur in people with carcinoid tumors, which are a type of slow-growing cancer. These tumors can release hormones, like serotonin, into the bloodstream, causing symptoms such as flushing, diarrhea, wheezing, and abdominal pain [2]. Byvalson is indicated for the treatment of adults with carcinoid syndrome [1].
How does Byvalson work?
Byvalson is a combination of the drugs lanreotide acetate and octreotide acetate. These medications are somatostatin analogs that work by inhibiting the release of hormones from neuroendocrine tumors, thereby helping to control the symptoms associated with carcinoid syndrome [1].
Sources:
[1] https://www.byvalson.com/financial-assistance
[2] https://www.cancer.gov/types/neuroendocrine/patient/carcinoid-treatment-pdq